The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan

Atherosclerosis

Volumn 141, Issue 2, 1998, Pages 259-264

  Ko, Yu Lin ^a   Ko, Yu Shien ^a   Wang, Shu Mei ^a   Hsu, Lung An ^a   Chang, Chi Jen ^a   Chu, Po Hsien ^a   Cheng, Nye Jan ^a   Chen, Wei Jan ^a   Chiang, Chen Wen ^a   Lee, Ying Shiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Coronary disease; Paraoxonase; Polymorphism

Indexed keywords

ARGININE; ARYLESTERASE; GLYCINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT;

ALLELES; AMINO ACID SUBSTITUTION; ARYLDIALKYLPHOSPHATASE; CHINA; CORONARY DISEASE; ESTERASES; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TAIWAN;

EID: 0032401550     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00179-8     Document Type: Article

References (37)

1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl J Med. 330:1994;1041-1046.
2. Chamberlain JC, Galton DJ Genetic susceptibility to atherosclerosis. Br Med Bull. 40:1990;917-940.
3. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Atveiler D, Luc G, Bard JM, Bara L, Richard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond). 359:1992;641-644.
4. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
5. Fumeron F, Betoulle D, Lue G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard J-M, Fruchart J-C Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 96:1995;1664-1671.
6. Ordovas JM, Schaefer EJ, Salem D, Ward RH, Glueck CJ, Vergani C, Wilson PWF, Karathanasis SK Apolipoprotein A-1 gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. New Engl J Med. 314:1986;671-677.
7. Ferns GAA, Stocks J, Ritchie C, Galton DJ Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet. 11:1985;300-303.
8. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC, Apfelbaum M, Cambien F, Tiret L Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res. 36:1995;2141-2146.
9. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 34:1993;421-428.
10. Gerdes C, Gerdes LU, Hansen PS, Faergeman O Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation. 92:1995;1765-1769.
11. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Cambien F fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM study. Circulation. 93:1996;440-449.
12. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New Engl J Med. 334:1996;1090-1094.
13. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest. 96:1995;2882-2891.
14. Mackness MI, Arrol S, Abbott C, Durrington PN Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
15. Witztum JL The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
16. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, Mclntyre TM, La Du BN, Fogelman AM, Berliner JA Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest. 95:1995;774-782.
17. Playfer JR, Eze CL, Bullen MF, Evans DAP Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J Med Genet. 13:1976;337-342.
18. Furlong CE, Richter RJ, Seidel SL, Motulsky AG Role of genetic polymorphism of human plasma paraoxonase arylesterase in hydrolysis of the insecticide metabolites chlorphyrifosos oxon and paraoxon. Am J Hum Genet. 43:1988;230-238.
19. La Du BN Invited editorial: the human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 43:1988;227-229.
20. Adkins S, Gan KN, Mody M, La Du BN Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet. 52:1993;598-608.
21. Garin MCB, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J Paraoxonase polymorphism Met-Leu 54 is associated with modified serum concentrations of the enzyme: a possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest. 99:1997;62-66.
22. Leviev I, Negro F, James RW Two alleles of the human paraoxonase gene produce different amounts of mRNA: an explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met 54) polymorphism. Arterioscler Thromb Vasc Biol. 17:1997;2935-2939.
23. McElveen J, Mackness MI, Colley CM, Peard T, Warner S, Walker CH Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem. 32:1986;671-673.
24. Ruiz J, Blanche H, James RW, Garin MCB, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type II diabetes. Lancet. 346:1995;869-872.
25. Serrato M, Marian AJ A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest. 96:1995;3005-3008.
26. Odawara M, Tachi Y, Yamashita K Paraoxonase polymorphism (Gln 192-Arg) is associated with coronary heart disease in Japanese non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 82:1997;2257-2260.
27. Antikainen M, Murtomaki S, Syvanne M, Pahlman R, Tahvanainen E, Jauhiainen M, Frick MH, Ehnholm C The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest. 98:1996;883-885.
28. Herrmann SM, Blanc H, Poirier O, Arveiler D, Luc G, Evans A, Marques-Vidal P, Bard JM, Cambien F The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis. 126:1996;299-303.
29. Suehiro T, Nakauchi Y, Yamamoto M, Arii K, Itoh H, Hamashige N, Hashimoto K Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int J Cardiol. 57:1996;69-73.
30. Ko YL, Hsu TS, Wu SM, Ko YS, Chang CJ, Wang SM, Chen WJ, Cheng NJ, Kuo CT, Chiang CW, Lee YS The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals. Hum Genet. 98:1996;176-177.
31. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, Chiang CW, Lee YS Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet. 100:1997;327-333.
32. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, Chen WJ, Hsu TS, Kuo CT, Chiang CW, Lee YS Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet. 100:1997;210-214.
33. Sanghera DK, Saha N, Aston CE, Kamboh MI Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 17:1997;1067-1073.
34. Saha N, Roy AC, Teo SH, Tay JSH, Ratnam SS Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet. 40:1991;277-282.
35. Hegele RA, Brunt JH, Connelly PW Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol. 15:1995;861-871.
36. Hegele RA, Brunt JH, Connelly PW A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol. 15:1995;89-95.
37. Nevin DN, Zambon A, Furlong CE, Richter RJ, Humbert R, Hokanson JE, Brunzell JD Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol. 16:1996;1243-1249.